P52732 (KIF11_HUMAN) Homo sapiens (Human)

Kinesin-like protein KIF11 UniProtKBInterProSTRINGInteractive Modelling

1056 aa; Sequence (Fasta)

Available Structures

62 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Pseudo-atomic model of microtubule-bound human kinesin-5 motor domain in presence of adp.alfx (NECK… Heteromer
Q2HJ86; Q6B856;
6-366
MG;GTP;GDP;TA1;AF3;ADP;
Assess
Pseudo-atomic model of microtubule-bound human kinesin-5 motor domain in the ADP.AlFx state, based … Heteromer
Q2HJ86; Q6B856;
6-366
MG;GTP;GDP;TA1;AF3;ADP;
Assess
Model of human kinesin-5 motor domain (3HQD) and mammalian tubulin heterodimer (1JFF) docked into t… Heteromer
Q2HJ86; Q6B856;
6-366
MG;GTP;GDP;TA1;ANP;
Assess
Pseudo-atomic model of microtubule-bound human kinesin-5 motor domain in the ADP state, based on cr… Heteromer
Q2HJ86; Q6B856;
9-365
GTP;GDP;TA1;MG;ADP;
Assess
Human kinesin-5 motor domain in the GSK state bound to microtubules (Conformation 2) Heteromer
P02554; Q2XVP4;
15-369
MZK;G2P;MG;
Assess
Human kinesin-5 motor domain in the GSK-1 state bound to microtubules (Conformation 1) Heteromer
P02554; Q2XVP4;
15-369
G2P;MG;MZK;
Assess
Human kinesin-5 motor domain in the AMPPNP state bound to microtubules Heteromer
P02554; Q2XVP4;
17-366
G2P;MG;GTP;ANP;
Assess
Model of human kinesin-5 motor domain (1II6, 3HQD) and mammalian tubulin heterodimer (1JFF) docked … Heteromer
Q2HJ86; Q6B856;
16-365
GTP;MG;GDP;TA1;
Assess
Crystal structure of human kinesin Eg5 in complex with 3-(((2-Aminoethyl)sulfanyl)(3-ethylphenyl) p…homo-3-mer17-366
ADP;MG; 15×CL;V02;
Assess
Crystal structure of human kinesin Eg5 in complex with (R)-2-amino-3-((4-chlorophenyl)diphenylmethy…homo-3-mer17-365
ADP;X2O;MG;
Assess
Intermediate state of human kinesin Eg5 in complex with Ispinesibhomo-3-mer17-364
ADP;CL;G7X;MG;PO4;
Assess
Crystal structure of human kinesin Eg5 in complex with (R)-2-amino-3-((S)-2-methyl-1,1-diphenylbuty…homo-3-mer17-364
2XA;MG;ADP;CL;SO4;
Assess
Crystal Structure of the Mitotic Kinesin Eg5 in Complex with Mg-ADP.homo-2-mer16-365
NO3;MG;ADP;
Assess
Eg5-2homo-2-mer16-365
ADP;MG;
Assess
Eg5-1homo-2-mer16-364
MG;NO3;ADP;
Assess
The Crystal Structure of Mitotic Kinesin Eg5 from Biortushomo-2-mer17-364
ADP;MG;EDO;MES;GOL;NO3;
Assess
Eg5-inhibitor complexhomo-2-mer17-364
ADP;GCE;MG;PEG;
Assess
Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 15homo-2-mer16-362
MG;ADP;K01;
Assess
The structure of human kinesin-like motor protein Kif11/KSP/Eg5 in complex with ADP and enastrol.homo-2-mer18-363
K5E;ADP;MG;
Assess
The neck-linker and alpha 7 helix of Homo sapiens Eg5 fused to EB1homo-2-mer371-391
Assess
Kinesin spindle protein Eg5 in complex with ATP-competitive inhibitor PVZB1194monomer15-369
B4S;
Assess
Eg5 motor domain in complex with STLC-type inhibitor PVEI0021 (P21 type)monomer17-367
ADP;MG;4C5;SO4;NA;
Assess
Crystal structure of the mitotic kinesin eg5 in complex with mg-adp and n-(3-aminopropyl)-n-((3-ben…monomer17-367
MG;2AZ;ADP;
Assess
Eg5 motor domain in complex with STLC-type inhibitor PVEI0021 (C2 type)monomer17-367
ADP;MG;4C5;SO4;NA;
Assess
Eg5-inhibitor complexmonomer16-366
ADP;MG;EOK;
Assess
Human kinesin Eg5 motor domain in complex with AMPPNP and Mg2+monomer17-366
ANP;PO4;MG;
Assess
Human Eg5 motor domain mutant Y82Fmonomer16-365
MG;ADP;PEG;
Assess
Crystal structure of human kinesin Eg5 in complex with (S)-dimethylenastronmonomer17-366
ADP;MG;EGB;
Assess
Eg5 motor domain mutant Y231Fmonomer16-365
ADP;MG;
Assess
The mitotic kinesin Eg5 in complex with Mg-ADP and ispinesibmonomer17-366
MG;ADP;CL;G7X;
Assess
Kinesin spindle protein Eg5 in complex with STLC-type inhibitor PVEI0138monomer17-366
ADP;MG;5C5;SO4;
Assess
Crystal structure of human kinesin Eg5 in complex with (R)-mon97, a new monastrol-based inhibitor t…monomer15-364
MG;K;CL;ADP;MOY;PG4;
Assess
Crystal structure of human kinesin Eg5 in complex with 2-Amino-5-(3-methylphenyl)-5,5-diphenylpenta…monomer17-366
ADP;MG;DQ6;DQ7;
Assess
Human Eg5 motor domain mutant R234Cmonomer16-365
ADP;MG;
Assess
Eg5 motor domain mutant E162Smonomer16-364
ADP;
Assess
Eg5 complex 1monomer16-364
ADP;CL;CO;CD;6LX;
Assess
Co-crystal structure of the human kinesin Eg5 with a novel tetrahydro-beta-carbolinemonomer16-364
MG;ADP;L31;NO3;CL;PEG;
Assess
Human Eg5 in complex with S-trityl-L-cysteinemonomer18-366
ADP;ZZD;KEN;MG;
Assess
Eg5-inhibitor complexmonomer16-364
ADP;MG;GCE;
Assess
Eg5(WT) complexmonomer16-364
ADP;CD;CL;6LX;
Assess
Human Eg5 motor domain mutant E344Kmonomer17-364
MG;ADP;
Assess
Eg5-inhibitor complexmonomer17-364
ADP;MG;EOK;
Assess
Intermediate and final states of human kinesin Eg5 in complex with S-trityl-L-cysteinemonomer17-364
ADP;MG;ZZD;
Assess
Crystal structure of human kinesin Eg5 in complex with (R)-fluorastrolmonomer17-364
ADP;MG;X7E;
Assess
Eg5-3monomer16-363
ADP; 11×CD; 10×CL;CO;CA;
Assess
Human Eg5 motor domain bound to Mg-ADP and monastrolmonomer18-364
MG;ADP;NAT;
Assess
Crystal structure of the motor protein KSP in complex with ADP and monastrolmonomer16-362
MG;ADP;NAT;
Assess
Crystal structure of human kinesin Eg5 in complex with (S)-enastronmonomer18-364
ADP;MG;KZ9;
Assess
X-ray structure of mitotic kinesin-5 (KSP, KIF11, Eg5)in complex with the hexahydro-2H-pyrano[3,2-c…monomer16-362
ADP;EMQ;
Assess
Crystal structure of the mitotic kinesin eg5 (ksp) in complex with mg-adp and (r)-4-(3-hydroxypheny…monomer17-363
MG;3QC;ADP;
Assess
Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 33monomer16-362
ADP;MG;K02;
Assess
Crystal structure of KSP in complex with ADP and thiophene containing inhibitor 37monomer16-362
ADP;MG;K03;
Assess
Eg5 - New allosteric binding sitemonomer18-363
ADP;MG;4A2;EPE;PEG;
Assess
Crystal structure of human kinesin Eg5 in complex with 1-(3-(((2-Aminoethyl)thio)diphenylmethyl)phe…monomer18-363
ADP;MG;DQ8;CL;
Assess
Crystal structure of KSP in complex with inhibitor 30monomer18-362
MG;ADP;K30;
Assess
crystal structure of KSP in complex with inhibitor 13monomer18-362
MG;ADP;N2T;
Assess
Crystal structure of KSP in complex with inhibitor 1monomer18-362
MG;ADP;L47;
Assess
Crystal Structure of KSP in complex with Inhibitor 1monomer18-362
MG;ADP;MKR;
Assess
crystal structure of KSP in complex with inhibitor 19monomer18-362
MG;ADP;N4T;
Assess
crystal structure of KSP in complex with inhibitor 6monomer18-362
MG;ADP;N5T;
Assess
crystal structure of KSP in complex with inhibitor 9hmonomer18-362
MG;ADP;N9H;
Assess
Crystal Structure of KSP in Complex with Inhibitor 22monomer18-362
MG;ADP;MKK;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ken.1.Amonomer0.7818-366
ADP;ZZD;100.00
Assess
6l5j.2.Amonomer0.71374-516
14.49
Assess
7ju4.1.Jmonomer0.70421-557
20.77
Assess
7d6e.1.Amonomer0.53733-811
9.33
Assess